Washington Research Foundation
Washington Research Foundation supports research and technology commercialization through grants to nonprofit research institutions and investments in early-stage Washington startups, focusing on life sciences and enabling technologies. It aims to advance academic research and help innovations reach the market for public benefit.
Facts
- HQ
- Seattle, WA, US
- Founded
- 1981
- Employees
- 11
- Invests in
- We invest in people and partnerships through grantmaking and startup investments. We help to move ideas forward by supporting researchers and entrepreneurs who advance life-changing innovations, and we work closely with the institutions and organizations that underpin this work.
Is this your organization? Claim it
BrainChild Bio Raises $116M Series A on Sept. 8 to Fund Phase 2 B7-H3 CAR T Trial for DIPG
BrainChild Bio raised $116 million in a Series A on Sept. 8 to fund a registrational Phase 2 trial of BCB-276, a B7-H3 CAR T therapy delivered directly into cerebrospinal fluid for DIPG, and to advance a triple-antigen glioblastoma program. The Seattle Children’s spinout aims to bypass the blood-brain barrier with intrathecal delivery after promising early survival signals.
BrainChild Bio raises $116M Series A to fund Phase 2 CAR T trial for childhood DIPG
Seattle startup BrainChild Bio raised $116 million in Series A funding to advance a CAR T cell therapy for diffuse intrinsic pontine glioma (DIPG) and to support development of additional pediatric and adult brain tumor CAR T programs. The financing will fund a pivotal ILLUMINATE Phase 2 registration-stage trial and was led by an undisclosed private family fund and foundation, with participation from Seattle Children’s and WRF Capital.
BrainChild Bio Raises $116M Series A to Fund Phase 2 Pivotal Trial of BCB-276 for DIPG
BrainChild Bio raised $116 million in a Series A to fund the ILLUMINATE Phase 2 pivotal trial of BCB-276 for diffuse intrinsic pontine glioma (DIPG) and to advance BCB-214 and other CAR T programs for pediatric and adult brain tumors.
By Washington Research…
See all 6Washington Research Foundation awards $274,849 to WSU’s Jon Oatley to advance Alphatide, a nonhormonal male contraceptive
Washington Research Foundation awarded $274,849 to WSU’s Jon Oatley to advance a nonhormonal, reversible male contraceptive centered on Alphatide, a peptide that blocks ARRDC5–TEX38 interaction to stop sperm maturation without affecting hormones. The grant builds on a prior $100,000 phase 1 award that identified TEX38 as an essential partner of ARRDC5 and supported early development of the peptide lead candidate.
Washington Research Foundation grants $272,500 to UW’s Aman Garg to advance FlexLock shape-changing guide catheter for complex PCI
Washington Research Foundation awarded Aman Garg $272,500 to continue development of the FlexLock Guide Catheter, a shape-changing, metamaterial-tip device designed to anchor guide catheters during complex PCI procedures and improve stability without blocking blood flow.
Washington Research Foundation Welcomes Ninth Cohort of WRF Venture Analysts, Raising Total Participants to 39
Washington Research Foundation has onboarded its ninth cohort of WRF Venture Analysts, bringing total program participation to 39; the one-year, part-time program places Washington graduate students and postdocs to evaluate grant and investment opportunities while gaining commercialization and entrepreneurship experience.
People
-
Orin Levine Executive, President & CEO
Online
Questions about Washington Research Foundation
What is Washington Research Foundation?
Washington Research Foundation is a nonprofit based in Seattle, WA, US that supports research and technology commercialization through grants to nonprofit research institutions and investments in early-stage Washington startups.
What is Washington Research Foundation known for?
Washington Research Foundation focuses on life sciences and enabling technologies, helping academic research reach the market for public benefit.
What has Washington Research Foundation been in the news for?
WebProNews and GeekWire reported in September 2026 on BrainChild Bio's plans for a Phase 2 CAR T trial for childhood DIPG. BrainChild Bio, Inc. also announced in September 2026 plans for a Phase 2 pivotal trial of BCB-276 for DIPG.
Who are the people behind Washington Research Foundation?
Orin Levine is president and CEO of Washington Research Foundation.
Where is Washington Research Foundation based?
Washington Research Foundation is based in Seattle, WA, US.
When was Washington Research Foundation founded?
Washington Research Foundation was founded in 1981.